MARKET

ICU

ICU

SeaStar Medical Holding Corp
NASDAQ
3.120
+0.140
+4.70%
After Hours: 3.196 +0.076 +2.42% 18:00 06/26 EDT
OPEN
2.970
PREV CLOSE
2.980
HIGH
3.278
LOW
2.960
VOLUME
39.10K
TURNOVER
--
52 WEEK HIGH
12.50
52 WEEK LOW
2.070
MARKET CAP
12.47M
P/E (TTM)
-0.6528
1D
5D
1M
3M
1Y
5Y
1D
SeaStar Medical amends prior 8-K on ex-CEO Green separation payout, says settlement exceeds earlier disclosure
PUBT · 3d ago
SeaStar Medical announces new CD-10-PCS codes for SCD therapy
TipRanks · 3d ago
SeaStar Medical's Selective Cytopheretic Device Receives Dedicated International Classification of Diseases Codes From U.S. CMS, Facilitating Future Billing Procedures
Benzinga · 4d ago
SEASTAR MEDICAL HOLDING CORP - NEW ICD-10-PCS CODES EFFECTIVE OCTOBER 1, 2026
Reuters · 4d ago
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
Barchart · 4d ago
SeaStar Medical CEO to present at Virtual Investor Summit Conference
PUBT · 5d ago
Weekly Report: what happened at ICU last week (0615-0619)?
Weekly Report · 5d ago
SeaStar Medical to Present at Upcoming Investor Summit Conference
Barchart · 5d ago
More
About ICU
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICU stock methods without spending real money on the virtual paper trading platform.